2254-62.2細(xì)胞

是否是腫瘤細(xì)胞： 0

物種來源： 倉鼠

生長狀態(tài)： 貼壁生長

運輸方式： 凍存運輸

數(shù)量： 大量

器官來源： 腎臟

細(xì)胞形態(tài)： 成纖維樣

ATCC Number： CRL-8544?

Designations: 2254-62.2

Depositors: Genentech, Inc.

2254-62.2細(xì)胞Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: adherent

Organism: hamster

Morphology: fibroblast

Source: Organ: kidney

Permits/Forms: 2254-62.2細(xì)胞In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Comments: This line was derived from BHK-21(c-13) (see ATCC CCL-10).

This line has been used as a host for transformation with expression vectors containing selectable and amplifiable marker DNAs (e.g., Factor VIII).

Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose and supplemented with 100 nM methotrexate, 93%; dialyzed fetal bovine serum, 7%

Temperature: 37.0°C

2254-62.2細(xì)胞Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended

Medium Renewal: Every 2 to 3 days

Remove medium, rinse with fresh 0.25% trypsin, remove trypsin and incubate the flask at 37C until the cells detach (about 5 to 10 minutes). Add fresh medium, aspirate and dispense into new flasks.

References: 3983: Capon DJ, et al. 2254-62.2細(xì)胞Preparation of functional human factor VIII in mammalian cells using methotrexate based selection. US Patent 4,965,199 dated Oct 23 1990